hpn217
abbvie
['hpn217']
$harp up &gt;130% today! interim ph1 results from hpn217 trial in r/r mm presented at #ash22 on sunday data showed 77% orr &amp; hpn217 clinically active across wide dose range see our blog for a full table of all #ash presentations $xbi $ibb #biotech
FDA Catalyst Calendar, Big Mover™ stocks to watch, & Model Portfolios. Database & tools to make you a profitable biotech stock investor. Try Free https://t.co/5njnanr11i